Research Overview of Ultima-Halotestin
Ultima-Halotestin is a fluoxymesterone-based research compound manufactured by Ultima Pharmaceuticals, designed specifically for in-vitro laboratory studies investigating androgenic steroid mechanisms. Fluoxymesterone belongs to the 17α-alkylated anabolic-androgenic steroid class, structurally modified from testosterone with specific alterations that create unique binding characteristics and metabolic properties. Researchers at Stroid UK Shop utilise this compound to examine androgenic receptor interactions, protein synthesis pathways, and steroid hormone metabolism in controlled laboratory environments.
Scientific Applications and Research Potential
Laboratory investigations with Ultima-Halotestin focus on examining the compound’s distinctive androgenic properties and its effects on cellular mechanisms. The 11β-hydroxy modification distinguishes fluoxymesterone from other androgenic compounds, making it valuable for comparative studies in steroid biochemistry research. Academic institutions examine this compound alongside other fluoxymesterone research materials to understand structure-activity relationships and receptor binding specificity. Research protocols often investigate the compound’s interaction with androgen receptors, glucocorticoid pathways, and hepatic enzyme systems. Scientists studying androgenic steroid pharmacology appreciate the compound’s unique profile for examining tissue-selective effects and metabolic transformations. Comparative studies frequently evaluate fluoxymesterone mechanisms against other research compounds available in SARM collections and peptide research libraries to establish comprehensive understanding of androgenic modulation.
Technical Specifications and Handling
| Parameter | Specification |
|---|---|
| Active Ingredient | Fluoxymesterone |
| Manufacturer | Ultima Pharmaceuticals |
| CAS Number | 76-43-7 |
| Molecular Formula | C₂₀H₂₉FO₃ |
| Molecular Weight | 336.44 g/mol |
| Storage Requirements | Room temperature, dry conditions |
| Research Classification | Androgenic steroid compound |
Laboratory storage protocols require maintaining Ultima-Halotestin in controlled temperature environments away from moisture and direct light exposure. Proper handling procedures ensure compound stability throughout research periods, with documentation of storage conditions essential for reproducible experimental results.
Compliance and Laboratory Use
Ultima-Halotestin is manufactured exclusively for in-vitro research applications and laboratory analysis. This compound is not intended for human consumption, therapeutic use, or any application outside controlled scientific research environments. Researchers must maintain appropriate institutional oversight, safety protocols, and documentation when conducting studies with this material. All investigations should comply with relevant laboratory safety guidelines and institutional review requirements for androgenic steroid research compounds.
